REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,283,609 | $97,535,422 | 8.32% |
| Essex Woodlands Management, Inc. | 457,085 | $8,437,789 | 4.70% |
| Evolutionary Tree Capital Management, LLC | 180,654 | $3,334,873 | 3.20% |
| Antara Capital LP | 5,239,600 | $96,723,000 | 2.71% |
| Ghost Tree Capital, LLC | 300,000 | $5,538,000 | 2.36% |
| Jericho Capital Asset Management L.P. | 935,669 | $17,272,450 | 1.28% |
| Tri Locum Partners LP | 166,300 | $3,070,000 | 1.24% |
| Integral Health Asset Management, LLC | 240,000 | $4,430,400 | 0.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 875,496 | $16,161,656 | 0.93% |
| Rhenman & Partners Asset Management AB | 438,000 | $8,085,480 | 0.84% |
| Antara Capital LP | 1,500,000 | $27,690,000 | 0.78% |
| Polar Capital Holdings Plc | 4,848,633 | $89,505,765 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $2,214,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 114,173 | $2,107,634 | 0.43% |
| Perceptive Advisors | 729,097 | $13,459,131 | 0.38% |
| Waypoint Capital Advisors, LLC | 53,989 | $996,637 | 0.34% |
| Numerai GP LLC | 26,444 | $488,156 | 0.33% |
| Ghisallo Capital Management LLC | 100,000 | $1,846,000 | 0.33% |
| Banco BTG Pactual S.A. | 24,200 | $446,732 | 0.26% |
| BFSG, LLC | 67,793 | $1,251 | 0.25% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.